Amarin Appoints Mark W. Salyer to New Position of Chief Commercial Officer

BEDMINSTER, N.J. and DUBLIN, Ireland, Sept. 13, 2017 -- (Healthcare Sales & Marketing Network) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that Mark W. Salyer has joined Amarin as Chief Commercial Officer. In this newly created position, Mr. Sa... Biopharmaceuticals, Cardiology, Personnel Amarin, Vascepa, icosapent
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news